Gene-environment interactions: key to unraveling the mystery of Parkinson's disease - Test2 - elhamkhani - TriplyDB

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

http://www.wikidata.org/entity/Q28388674

about

Preventive effects of regular physical exercise against cognitive decline and the risk of dementia with age advancement Protective Effects of Physical Exercise in Alzheimer's Disease and Parkinson's Disease: A Narrative Review Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases Molecular aspects of dopaminergic neurodegeneration: gene-environment interaction in parkin dysfunction Protective Microglia and Their Regulation in Parkinson's Disease Disease-toxicant interactions in Parkinson's disease neuropathology Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression Heat shock proteins in neurodegenerative disorders and aging Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.Swallowing safety in Parkinson's disease after zona incerta deep brain stimulation.Alterations in energy/redox metabolism induced by mitochondrial and environmental toxins: a specific role for glucose-6-phosphate-dehydrogenase and the pentose phosphate pathway in paraquat toxicity Stem cell transplantation in neurological diseases: improving effectiveness in animal models Significant study of population stratification, sensitivity analysis and trim and fill analyses on GBA mutation and Parkinson's disease.Industrial toxicants and Parkinson's disease.Using DNA methylation to understand biological consequences of genetic variability.SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration.Susceptibility to a parkinsonian toxin varies during primate development Long-lasting transcriptional refractoriness triggered by a single exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.A 5-Year Follow-up Study on the Relationship between Obstructive Sleep Apnea and Parkinson Disease.Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease NADPH oxidases: novel therapeutic targets for neurodegenerative diseases Glucocerebrosidase L444P mutation confers genetic risk for Parkinson's disease in central China Advances in the treatment of visual hallucinations in neurodegenerative diseases.Caspase-1 clipping causes complications for α-synuclein.Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.Antioxidant gene therapy against neuronal cell death.Adaptation and sensitization to proteotoxic stress.How can we improve clinical trials in amyotrophic lateral sclerosis?The role of central nervous system development in late-onset neurodegenerative disorders.The bad, the good, and the ugly about oxidative stress.Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.Single-chain fragment variable passive immunotherapies for neurodegenerative diseases.Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model.Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease.Antioxidant modulation in restoring mitochondrial function in neurodegeneration.The neurotoxicity of iron, copper and cobalt in Parkinson's disease through ROS-mediated mechanisms.

P2860

Q26797293-39A0E7CB-07D6-4B91-9669-81CEDFADE6A3 Q26801815-F98715AE-D3E4-4607-B261-D6FD7C78664E Q26821835-AAD58C1A-BAE5-44CE-8DB3-0D1FB672D146 Q26849699-CE1ECA81-B449-40DD-9EA0-05CE5F66171F Q28079731-3F4AC858-E9F8-41A3-8DBF-C80E8FAA2264 Q29248297-DD381784-A3F9-463A-B852-F293358B46D1 Q30359033-949353AF-8BBC-4DA7-9BD0-45D24ACFA29F Q30414556-B4EA965F-E42B-418E-B932-778679C862D5 Q33771694-644C2B88-4FA5-44A7-B6DC-8A8D602A4B3C Q33810121-9DF0378A-3A71-466E-9A5E-0DBB547AC9C7 Q34211654-6C6BBA1F-50D5-46CD-8E33-E547526A5917 Q34391064-B07A238B-26E7-4F2F-8216-D1C548E1E5B5 Q35045322-04981381-8466-440C-A5DE-FB18AB657D02 Q35822952-1070984B-9156-418A-AC50-8B5786BBEACE Q35832672-934B100A-F089-4DCE-AE90-88BD9E90937F Q35859538-E3DC5478-4A70-4192-A37D-F0F818DE4212 Q35875886-63D12530-2638-4C85-9E99-88B2E083507E Q35907253-66C99FAA-AE53-418D-81C6-8F240689A5C4 Q36019710-E5A4C465-2624-40CF-BF98-6D9D99BECDBE Q36176040-6D564C9A-5321-4421-9DFA-589EEB981C52 Q36323283-03F8DF2F-E9C9-45F3-A382-B5D3CCFF2E35 Q36326535-08404531-D01B-453E-AB2B-021F55C07C59 Q36336772-2D49FD83-BFED-4FDE-AAE3-4A84C1D2AEA6 Q36513434-C2792EB2-9392-4704-A7C8-5F7C1F8F57E3 Q37029454-0A8C9269-847A-481C-99F2-F7F6AC002FD7 Q37247475-D48D9E06-F22C-4314-AF90-582D2CBE03D0 Q37292275-2225D59E-FB5A-4B76-9F57-45E3654E0370 Q37320854-AD7BA4D7-437A-4C84-BB7C-D26161766C81 Q37591146-439B6A2C-3C7D-4982-86FC-C8740ECD362E Q37647941-21D27ABC-C5B0-4219-96E2-35A51870C2B4 Q37651678-F76FBBAF-1CF0-4093-8435-BBD28CB3C89B Q37938694-5F231DAC-2833-4F5C-BC80-081BF36A8AA8 Q38008841-8019B692-9926-4552-9D01-CDB0D2F6135E Q38012450-9C712D44-6D3C-4064-8AC1-3680D3A92C8C Q38021940-33E811C1-C952-4E56-98B8-43126401A175 Q38139218-BDC492AF-16FA-4E03-9A5E-D87077065C8A Q38366271-90D6DCBF-05D4-4003-B3CB-98B6D4EDF9AD Q38722255-EF9324E7-BF52-437C-B800-1131352BC930 Q38807381-AC40D5EA-25D1-45A1-AD1A-BE676805E3D8 Q38878661-7A251492-77F0-4528-A668-DF9BE08A1FC5

P2860

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

http://www.wikidata.org/entity/Q28388674

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@ast

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@en

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@nl

type

label

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@ast

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@en

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@nl

prefLabel

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@ast

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@en

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@nl

P1433

Q28388674-A20D9735-C4FE-4852-A55B-25D1DC7FB39E

P1476

Q28388674-D99D9E08-7227-4F0C-B25A-A2E21001A83E

P2093

Q28388674-2354D8CA-7C8B-43E4-AF5F-C1E1CF31F852

P2860

Q28388674-00682A72-0A60-4EB2-B259-57DA274C51DF

Q28388674-017D01A9-09B1-49B6-9E03-9590344024D8

Q28388674-01A818F6-BC5A-4971-9640-F045D4A908F9

Q28388674-02183DD3-A703-467D-A5AA-36C20A3D5D45

Q28388674-02E323E4-A3B7-4C65-8810-96785C9C32A7

Q28388674-0441BB46-4E6E-484E-B2C2-B9F96CE10E46

Q28388674-0543D97B-99A4-47C6-B6B7-4030237801F1

Q28388674-064928F1-1386-4195-A333-8F0977872F3F

Q28388674-06EC0CD0-D205-4280-9993-74D2539B7CB8

Q28388674-070ADBB7-FF46-4C04-9A02-BE85EC569D1B

P304

Q28388674-C223F980-EC19-4538-8F3A-1AF923B43969

P31

Q28388674-C7896F2D-8BF6-4E94-808E-C49B8641A8D2

P3181

Q28388674-2507EB8C-13A9-4F57-B893-93900E0AF377

P356

Q28388674-E106A6A9-86D6-4DA0-A6DE-53ED2EED776E

P407

Q28388674-A29C1B2C-9FA8-4846-B436-DA0A29F2584B

P433

Q28388674-BB9BF7A0-F197-40D8-B89A-59F7737ABE4B

P478

Q28388674-C0DC26AD-B052-4D2A-8CCF-20A050D0C7D3

P50

Q28388674-90B5D047-454A-43EB-96DA-0DFAA979DC92

P577

Q28388674-31E175BF-0083-4FF7-9213-C831AFC780CD

P5875

Q28388674-7FF6D71A-9781-4890-8694-E6526DD0460F

P698

Q28388674-3A5EFEDB-9C96-4215-86B3-ED09F2FBF725

P921

Q28388674-25F5C10F-CD26-4AF8-88CC-8046161410DB

P932

Q28388674-AD311414-CEEB-40C3-B299-0B6860131B05

P3181

P356

J.PNEUROBIO.2011.03.005

P1433

Progress in Neurobiology

P1476

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

@en

P2093

Hui-Ming Gao

http://www.w3.org/2001/XMLSchema#string

P2860

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin

Parkinson's disease, pesticides, and glutathione transferase polymorphisms

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Parkinson's disease: from monogenic forms to genetic susceptibility factors

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

Pesticide/environmental exposures and Parkinson's disease in East Texas

Parkinsonism and occupational exposure to pesticides

Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity

P304

1-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2776686

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.PNEUROBIO.2011.03.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

Jau-Shyong Hong

P577

2011-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50865841

http://www.w3.org/2001/XMLSchema#string

P698

21439347

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3098527

http://www.w3.org/2001/XMLSchema#string